These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10082049)

  • 1. Cellular and biological therapies of gastrointestinal tumors: overview of clinical trials.
    Morse MA; Lyerly HK
    Ann Surg Oncol; 1999 Mar; 6(2):218-23. PubMed ID: 10082049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered dendritic cells for gastrointestinal tumor immunotherapy: opportunities in translational research.
    Bhargava A; Mishra D; Banerjee S; Mishra PK
    J Drug Target; 2013 Feb; 21(2):126-36. PubMed ID: 23061479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells: tools and targets for antitumor vaccination.
    den Brok MH; Nierkens S; Figdor CG; Ruers TJ; Adema GJ
    Expert Rev Vaccines; 2005 Oct; 4(5):699-710. PubMed ID: 16221071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy for gastrointestinal cancer: current status and strategies for improving efficacy.
    Elkord E; Hawkins RE; Stern PL
    Expert Opin Biol Ther; 2008 Apr; 8(4):385-95. PubMed ID: 18352844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic vaccination in patients with gastrointestinal malignancies. A review of immunological and clinical results.
    Mosolits S; Ullenhag G; Mellstedt H
    Ann Oncol; 2005 Jun; 16(6):847-62. PubMed ID: 15829493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of adoptive cellular immunotherapy of human cancer using ex-vivo gene transfer.
    Paul S; Calmels B; Acres RB
    Curr Gene Ther; 2002 Feb; 2(1):91-100. PubMed ID: 12108977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for metastatic colorectal cancer: present status and new options.
    Ellebaek E; Andersen MH; Svane IM; Straten PT
    Scand J Gastroenterol; 2012 Mar; 47(3):315-24. PubMed ID: 22214467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in specific immunotherapy for prostate cancer.
    Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
    Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunotherapy: new insights].
    Geissler M; Weth R
    Praxis (Bern 1994); 2002 Dec; 91(51-52):2236-46. PubMed ID: 12564040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy in gastrointestinal cancer: The current scenario and future perspectives.
    Abdul-Latif M; Townsend K; Dearman C; Shiu KK; Khan K
    Cancer Treat Rev; 2020 Aug; 88():102030. PubMed ID: 32505807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.
    Maxwell R; Luksik AS; Garzon-Muvdi T; Lim M
    Curr Neurol Neurosci Rep; 2017 Jun; 17(6):50. PubMed ID: 28488122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic therapies for gastrointestinal cancers.
    Levy B; Deeken JF; Holt G; Marshall JL
    Clin Colorectal Cancer; 2005 May; 5(1):37-49. PubMed ID: 15929805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of vaccines against self-antigens: the p53 paradigm.
    Chada S; Mhashilkar A; Roth JA; Gabrilovich D
    Curr Opin Drug Discov Devel; 2003 Mar; 6(2):169-73. PubMed ID: 12669451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immunotherapy for malignant gliomas.
    Lin Y; Okada H
    Expert Opin Biol Ther; 2016 Oct; 16(10):1265-75. PubMed ID: 27434205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cellular immunotherapy for hematological malignancies].
    Yasukawa M
    Rinsho Ketsueki; 2008 Oct; 49(10):1460-71. PubMed ID: 18833930
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune based therapies in cancer.
    Krüger C; Greten TF; Korangy F
    Histol Histopathol; 2007 Jun; 22(6):687-96. PubMed ID: 17357098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vaccine strategies against melanoma].
    Ghiringhelli F; Zitvogel L
    Med Sci (Paris); 2006 Feb; 22(2):183-7. PubMed ID: 16457760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current approaches to immunotherapy in noncolorectal gastrointestinal malignancies.
    Jesus VHF; Felismino TC; Barros E Silva MJ; Souza E Silva V; Riechelmann RP
    Clinics (Sao Paulo); 2018 Oct; 73(suppl 1):e510s. PubMed ID: 30365605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunobiology and gene-based immunotherapy of hepatocellular carcinoma.
    Geissler M; Mohr L; Ali MY; Grimm CF; Ritter M; Blum HE
    Z Gastroenterol; 2003 Nov; 41(11):1101-10. PubMed ID: 14648380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-HER2 vaccines: The HER2 immunotargeting future?].
    Ladjemi MZ; Jacot W; Pèlegrin A; Navarro-Teulon I
    Pathol Biol (Paris); 2011 Jun; 59(3):173-82. PubMed ID: 19481373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.